Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obicetrapib Dose-Finding in Japanese Statin-Treated Subjects with Dyslipidemia
jRCT2031220095Phase 2Completed
- Sponsor
- NewAmsterdam Pharma
- Start
- Jun 2022
- Modality
- Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of obicetrapib in dyslipidemia and hypercholesterolemia (4 arms), sponsored by NewAmsterdam Pharma. Started Jun 2022; status: completed.
02
Drugs
obicetrapib
03
Conditions
dyslipidemiahypercholesterolemia
Beyond the preview
Go deeper on jRCT2031220095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220095.